Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension (Q28287907)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension
scientific article

    Statements

    Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension (English)
    0 references
    L Narine
    0 references
    L K Hague
    0 references
    J H Walker
    0 references
    C Vicente
    0 references
    R Schilz
    0 references
    O Desjardins
    0 references
    T R Einarson
    0 references
    M Iskedjian
    0 references
    December 2005
    0 references
    21
    0 references
    2007-16
    0 references
    12
    0 references

    Identifiers

    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit